1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MADRIGAL PHARMACEUTICALS INC
Madrigal Pharmaceuticals Inc XNAS: MDGL

Madrigal Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Read More
432.89 1.68 (0.39%)
New 52W High in past week
281.2K
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Madrigal Pharmaceuticals Inc is on 08 Sep 2025 for the purpose of Morgan Stanley 23(rd) Annual Global Health Care Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
7.0 / 100
Momentum Score
Technically Moderately Bullish
66.8 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
466
1Yr Price target upside is 8%
13 analysts

24

S

8

W

0

O

3

T

SWOT Analysis

Madrigal Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..